FAF is hosting its inaugural Food Allergy Fund Innovation Forum on the West Coast on October, 21, 2026. Join us for an evening exploring two of the most exciting frontiers in food allergy research: from the immune system and microbiome to the biotech innovations working toward prevention, treatments, and ultimately a cure. Investors, entrepreneurs, patients, families, clinicians, scientists, and industry leaders, all in one room.
Date: Wednesday, October 21, 2026
Time: 4:00–6:30 p.m. (Program & Networking Reception)
Location: The Commonwealth Club,
110 The Embarcadero, San Francisco, CA
REGISTRATION IS CLOSED
EVENT AGENDA
Welcome Remarks: Ilana Golant | Founder & CEO, Food Allergy Fund
Panel: The Next Generation of Food Allergy Treatments
Ashley Dombkowski| CEO & President, Cellics Therapeutics
Dr. Nikole Kimes | CEO, Siolta Therapeutics
Dr. Brian Wong | Former CEO, RAPT Therapeutics
Thomas Goetz | Creator & Host, Drug Story Podcast (moderator)
Presentations: The FAF-Funded Science Shaping the Future of Food Allergy
Dr. Susan Lynch | Director, Benioff Center for Microbiome Medicine, UCSF
Dr. Carlotta Ronda | Principal Investigator, Innovative Genomics Institute, UC Berkeley
Dr. Michael Fischbach | Director, Microbiome Therapies Initiative, Stanford University
Dr. Alexander Marson | Director, Institute of Genomic Immunology, Gladstone-UCSF
Panel: The Investment Landscape in Food Allergy
Carol Suh | ARCH Venture Partners
Dr. Gijsbert Grotenbreg | a16z Bio + Health, Andreessen Horowitz
Dr. Uri Lopatin | CEO, Ukko & Operating Partner, Khosla Ventures
Ilana Golant | Founder & CEO, Food Allergy Fund (moderator)
Confirmed speakers include:
-

Ashley Dombkowski
CEO & President, Cellics Therapeutics
-

Dr. Michael Fischbach
Director, Microbiome Therapies Initiative,
Stanford University -

Thomas Goetz
Creator & Host, Drug Story Podcast
-

Dr. Gijsbert Grotenbreg
Venture Partner,
a16z Bio + Health -

Dr. Nikole Kimes
CEO, Siolta Therapeutics
-

Dr. Uri Lopatin
CEO, Ukko
-

Dr. Susan Lynch
Director, Benioff Center for Microbiome Medicine,
UCSF -

Dr. Alexander Marson
Director, Institute of Genomic Immunology,
Gladstone-UCSF -

Dr. Carlotta Ronda
Principal Investigator,
Innovative Genomics Institute,
UC Berkeley -

Carol Suh
Partner, ARCH Venture Partners
-

Dr. Brian Wong
Former President & CEO,
RAPT Therapeutics -

Greg Yap
Partner, Menlo Ventures